GlassScriptPhysician profile
Timothy P Morris
NPI 1942292578
$12,336.91
in general payments reported to CMS, 2019-2025
38 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,239 · 2020: $534 · 2021: $3,608 · 2022: $1,681 · 2023: $2,052 · 2024: $1,677 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,275.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,457.84 | 2021-2025 | Indigo System, Penumbra System |
| Abiomed | $1,136.12 | 2019-2025 | Impella |
| Abbott Laboratories | $1,024.52 | 2021-2025 | Aveir, Xience Skypoint, Perclose Prostyle |
| Astrazeneca Pharmaceuticals LP | $1,009.24 | 2019-2025 | Farxiga, Wainua |
| Shockwave Medical, INC | $943.92 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $890.25 | 2019-2025 | Avvigo Guidance System, Emblem Mri S-Icd, Watchman Access System |
| Inari Medical, INC. | $795.38 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $662.87 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $494.61 | 2019-2025 | Lifevest |
| Medtronic, INC. | $375.42 | 2021-2025 | Symplicity G3, Ffrangio |
| Novartis Pharmaceuticals Corporation | $321.66 | 2020-2025 | |
| Pfizer INC. | $304.92 | 2019-2025 | |
| Getinge USA Sales, LLC | $300.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $289.12 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $275.57 | 2019-2024 | Jardiance |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $240.99 | 2023 | Pantheris |
| Amgen INC. | $227.14 | 2019-2024 | Repatha |
| Edwards Lifesciences Corporation | $184.15 | 2019-2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Livanova USA, INC. | $181.82 | 2019 | |
| Cardiovascular Systems INC. | $179.27 | 2019-2022 | |
| Novo Nordisk INC | $173.85 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $155.47 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $114.27 | 2021-2022 | |
| Stryker Corporation | $104.47 | 2025 | Artix Mt |
| Irhythm Technologies, INC. | $102.59 | 2021 | |
| Merck Sharp & Dohme LLC | $74.57 | 2022-2023 | Verquvo |
| Scpharmaceuticals INC. | $54.83 | 2023-2024 | |
| Amarin Pharma, INC. | $43.56 | 2019-2020 | |
| Akcea Therapeutics, INC. | $38.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $31.74 | 2019-2024 | Dupixent |
| Tactile Systems Technology INC | $27.44 | 2024 | Entre Plus, Flexitouch Plus |
| Medicomp INC | $24.10 | 2024 | Telepatch Cardiac Monitor |
| Preventice Services, LLC | $23.06 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $22.87 | 2023 | Inpefa |
| Cardinal Health 200 LLC | $21.27 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $15.34 | 2024 | Arcalyst |
| Astellas Pharma US INC | $13.85 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.